Cabaletta Bio (CABA) Earnings Date, Estimates & Call Transcripts $1.34 +0.09 (+7.20%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$1.37 +0.03 (+2.16%) As of 05/2/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cabaletta Bio Earnings Summary Upcoming Earnings DateMay. 21Before Market OpensEstimatedConsensus EPS (Mar. 31) -$0.65 Actual EPS (Mar. 31) -$0.65 Cabaletta Bio posted Q4 2024 earnings on March 31, 2025, reporting an EPS of -$0.65, which hit analysts' consensus estimates of -$0.65. With a trailing EPS of -$2.34, Cabaletta Bio's earnings are expected to decrease next year, from ($2.34) to ($2.82) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)CABA Upcoming EarningsCabaletta Bio's Q1 2025 earnings is scheduled for Wednesday, May 21, 2025, with a conference call scheduled on Wednesday, May 14, 2025 at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Cabaletta Bio Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cabaletta Bio and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCABA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Cabaletta Bio Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.68-$0.63-$0.66Q2 20252-$0.73-$0.63-$0.68Q3 20252-$0.72-$0.65-$0.69Q4 20252-$0.69-$0.60-$0.65 FY 2025 8 -$2.82 -$2.51 -$2.67 Q1 20261-$0.71-$0.71-$0.71Q2 20261-$0.74-$0.74-$0.74Q3 20261-$0.72-$0.72-$0.72Q4 20261-$0.74-$0.74-$0.74 Cabaletta Bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/21/2025(Estimated)--------3/31/2025Q4 2024-$0.65-$0.65--$0.65--8/8/2024--$0.55-$0.56 -$0.01-$0.56--5/15/2024Q1 2024-$0.48-$0.51 -$0.03-$0.51--3/21/2024Q4 2023-$0.39-$0.46 -$0.07-$0.46--11/9/2023Q3 2023-$0.39-$0.37+$0.02-$0.37--8/10/2023Q2 2023-$0.47-$0.37+$0.10-$0.37--5/11/2023Q1 2023-$0.48-$0.45+$0.03-$0.45-- Cabaletta Bio Earnings - Frequently Asked Questions When is Cabaletta Bio's earnings date? Cabaletta Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based off last year's report dates. Learn more on CABA's earnings history. Did Cabaletta Bio beat their earnings estimates last quarter? In the previous quarter, Cabaletta Bio (NASDAQ:CABA) reported ($0.65) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.65). Learn more on analysts' earnings estimate vs. CABA's actual earnings. How much profit does Cabaletta Bio generate each year? Cabaletta Bio (NASDAQ:CABA) has a recorded net income of -$67.68 million. CABA has generated -$2.34 earnings per share over the last four quarters. What is Cabaletta Bio's EPS forecast for next year? Cabaletta Bio's earnings are expected to decrease from ($2.34) per share to ($2.82) per share in the next year. More Earnings Resources from MarketBeat Related Companies 2seventy bio Earnings Compass Therapeutics Earnings Aurora Cannabis Earnings Nuvectis Pharma Earnings Terns Pharmaceuticals Earnings Atea Pharmaceuticals Earnings Solid Biosciences Earnings DBV Technologies Earnings Foghorn Therapeutics Earnings Monopar Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback PlanMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of Earnings This page (NASDAQ:CABA) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cabaletta Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cabaletta Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
